ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,769Medicare Part D Prescriptions Filled, Including Refills

Rank: 116 out of 670

$636K Total Retail Price of All Prescriptions

Rank: 123 out of 670

318 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 318 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 318 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 4,809 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
SIMVASTATIN 431 266 1 4
LEVOTHYROXINE SODIUM 376 221 2 2
LISINOPRIL 373 226 3 3
HYDROCODONE-ACETAMINOPHEN 346 111 S3 4 1
OMEPRAZOLE 344 165 5 5
AMLODIPINE BESYLATE 249 158 6 7
FUROSEMIDE 230 142 7 6
METOPROLOL TARTRATE 218 129 8 9
SERTRALINE HCL 212 95 9 22
METOPROLOL SUCCINATE 207 75 10 12
METFORMIN HCL 202 124 11 8
NEXIUM 198 66 12 14
HYDROCHLOROTHIAZIDE 183 97 13 10
CYMBALTA 180 0 14 36
QUETIAPINE FUMARATE 177 0 15 84
ZOLPIDEM TARTRATE 160 58 16 23
FLUOXETINE HCL 149 31 17 55
RISPERIDONE 136 49 18 80
ATENOLOL 120 90 19 17
GABAPENTIN 115 51 20 11
TRAZODONE HCL 112 26 21 39
ATORVASTATIN CALCIUM 109 90 22 15
TRAMADOL HCL 108 44 23 21
BUPROPION XL 99 54 24 192
VENLAFAXINE HCL ER 96 18 25 97
RANITIDINE HCL 95 39 26 25
LYRICA 91 39 27 65
CLOPIDOGREL 90 44 28 24
POTASSIUM CHLORIDE 90 39 28 16
CRESTOR 86 50 30 18
WARFARIN SODIUM 83 64 31 13
METFORMIN HCL ER 81 25 32 63
CITALOPRAM HBR 77 45 33 20
CARVEDILOL 76 42 34 29
FENOFIBRATE 75 44 35 64
TOPIRAMATE 73 0 36 162
ENDOCET 71 27 S2 37 146
PANTOPRAZOLE SODIUM 68 29 38 41
SEROQUEL 68 0 38 182
GLIPIZIDE 65 19 40 67
KLOR-CON M20 63 16 41 57
CELEBREX 62 21 42 89
GLIMEPIRIDE 59 34 43 32
DIVALPROEX SODIUM ER 59 0 43 220
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 32 45 27
TAMSULOSIN HCL 56 32 46 30
ESCITALOPRAM OXALATE 55 18 47 78
MELOXICAM 55 24 47 33
LITHIUM CARBONATE 55 0 47 258
JANUVIA 53 14 50 53
ENALAPRIL MALEATE 53 31 50 49
DEXILANT 52 14 52 70
PLAVIX 51 29 53 34
PROAIR HFA 51 0 53 28
SEROQUEL XR 50 22 55 368
DIOVAN 50 0 55 48
GLIPIZIDE XL 50 38 55 113
ABILIFY 50 0 55 200
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 31, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.